Vivo Bio Tech Ltd — Others, 04-08-2025: AGM/EGM

Vivo Bio Tech shareholders have approved the increase in the company's Authorised Share Capital and the consequent alteration to its Memorandum of Association. This decision was passed through a Postal Ballot, including e-voting. The resolution saw overwhelming support, with 6,249,397 votes (99.81%) cast in favour, while 11,710 votes (0.19%) were against. This approval provides the company with enhanced flexibility for future capital-raising initiatives or strategic expansions, directly impacting its operational scope and potential for growth.